Ingevity Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -17.79%

Ingevity Corporation EBITDA Margin is -17.79% for the Trailing 12 Months (TTM) ending March 31, 2025, a -388.49% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Ingevity Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 6.17%, a -69.40% change year over year.
  • Ingevity Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 20.15%, a 22.52% change year over year.
  • Ingevity Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 16.44%, a -49.86% change year over year.
  • Ingevity Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 32.80%, a 5.16% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin